161 related articles for article (PubMed ID: 20177845)
1. CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance.
Bektas S; Bahadir B; Ucan BH; Ozdamar SO
Pathol Oncol Res; 2010 Dec; 16(4):569-77. PubMed ID: 20177845
[TBL] [Abstract][Full Text] [Related]
2. High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients.
Chen J; Tang D; Wang S; Li QG; Zhang JR; Li P; Lu Q; Niu G; Gao J; Ye NY; Wang DR
Tumour Biol; 2014 Mar; 35(3):2513-9. PubMed ID: 24241899
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
4. CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach.
Cao X; Cao D; Jin M; Jia Z; Kong F; Ma H; Wang Y; Jiang J
BMC Gastroenterol; 2014 Sep; 14():157. PubMed ID: 25212506
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer.
Chen J; Zhou SJ; Zhang Y; Zhang GQ; Zha TZ; Feng YZ; Zhang K
World J Gastroenterol; 2013 Apr; 19(13):2073-9. PubMed ID: 23599627
[TBL] [Abstract][Full Text] [Related]
6. Reduced N-Myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma.
Wang H; Wang W; Wang X; Cai K; Wu H; Ju Q; Huang Z; Gao X
Med Oncol; 2012 Dec; 29(5):3162-8. PubMed ID: 22528516
[TBL] [Abstract][Full Text] [Related]
7. Fascin expression is related to poor survival in gastric cancer.
Kim SJ; Kim DC; Kim MC; Jung GJ; Kim KH; Jang JS; Kwon HC; Kim YM; Jeong JS
Pathol Int; 2012 Dec; 62(12):777-84. PubMed ID: 23252866
[TBL] [Abstract][Full Text] [Related]
8. CD24 expression is associated with progression of gastric cancer.
Takahashi M; Nakajima M; Ogata H; Domeki Y; Ohtsuka K; Ihara K; Kurayama E; Yamaguchi S; Sasaki K; Miyachi K; Kato H
Hepatogastroenterology; 2013 Jun; 60(124):653-8. PubMed ID: 23159387
[TBL] [Abstract][Full Text] [Related]
9. The role of CD24 in various human epithelial neoplasias.
Lim SC; Oh SH
Pathol Res Pract; 2005; 201(7):479-86. PubMed ID: 16164042
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
Liu X; Yu H; Cai H; Wang Y
J Surg Oncol; 2014 Jun; 109(8):859-64. PubMed ID: 24619835
[TBL] [Abstract][Full Text] [Related]
12. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma.
Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH
Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
Jin EH; Lee DH; Jung SA; Shim KN; Seo JY; Kim N; Shin CM; Yoon H; Jung HC
World J Gastroenterol; 2015 Jan; 21(2):571-7. PubMed ID: 25593477
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and prognostic significance of CD24 in gallbladder carcinoma.
Liu B; Zhang Y; Liao M; Deng Z; Gong L; Jiang J; Lynn L; Wu K; Miao X
Pathol Oncol Res; 2011 Mar; 17(1):45-50. PubMed ID: 20567952
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques.
Dicken BJ; Graham K; Hamilton SM; Andrews S; Lai R; Listgarten J; Jhangri GS; Saunders LD; Damaraju S; Cass C
Ann Surg; 2006 Jan; 243(1):64-73. PubMed ID: 16371738
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
18. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
[TBL] [Abstract][Full Text] [Related]
19. Expression of galectin-3 in gastric adenocarcinoma.
Gomes TS; Oshima CT; Forones NM; De Oliveira Lima F; Ribeiro DA
Indian J Med Res; 2014 Jul; 140(1):69-76. PubMed ID: 25222780
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
